BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin X, Zhao Y, Song WM, Zhang B. Molecular classification and prediction in gastric cancer. Comput Struct Biotechnol J 2015;13:448-58. [PMID: 26380657 DOI: 10.1016/j.csbj.2015.08.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Tamilzhalagan S, Muthuswami M, Ganesan K. Juxtaposed genes in 7q21-22 amplicon contribute for two major gastric cancer sub-Types by mutual exclusive expression: MUTUAL EXCLUSIVE EXPRESSION AMONG 7q21-22 GENES. Mol Carcinog 2017;56:1239-50. [DOI: 10.1002/mc.22586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Guo X, Fu Y, Wang Z, Wang T, Li C, Huang T, Gao F, Li C. Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy. Oxid Med Cell Longev 2018;2018:4950705. [PMID: 29765497 DOI: 10.1155/2018/4950705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Wang Z, Chen G, Wang Q, Lu W, Xu M. Identification and validation of a prognostic 9-genes expression signature for gastric cancer. Oncotarget. 2017;8:73826-73836. [PMID: 29088749 DOI: 10.18632/oncotarget.17764] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
4 Matboli M, El-Nakeep S, Hossam N, Habieb A, Azazy AEM, Ebrahim AE, Nagy Z, Abdel-Rahman O. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. World J Gastroenterol 2016; 22(26): 5896-5908 [PMID: 27468184 DOI: 10.3748/wjg.v22.i26.5896] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Li L, Wang X. Identification of gastric cancer subtypes based on pathway clustering. NPJ Precis Oncol 2021;5:46. [PMID: 34079012 DOI: 10.1038/s41698-021-00186-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Heo YJ, Park C, Yu D, Lee J, Kim KM. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue. Sci Rep 2019;9:9675. [PMID: 31273278 DOI: 10.1038/s41598-019-46216-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Zhu X, Tian X, Sun T, Yu C, Cao Y, Yan T, Shen C, Lin Y, Fang JY, Hong J, Chen H. GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer. Mol Oncol 2018;12:1871-83. [PMID: 29957874 DOI: 10.1002/1878-0261.12351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
8 Peri S, Biagioni A, Versienti G, Andreucci E, Staderini F, Barbato G, Giovannelli L, Coratti F, Schiavone N, Cianchi F, Papucci L, Magnelli L. Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line. Int J Mol Sci 2021;22:7698. [PMID: 34299320 DOI: 10.3390/ijms22147698] [Reference Citation Analysis]
9 Xu Z, Feng J, Li Y, Guan D, Chen H, Zhai X, Zhang L, Li C, Li C. The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway. Chem Biol Interact 2020;328:109196. [PMID: 32687844 DOI: 10.1016/j.cbi.2020.109196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Díaz Del Arco C, Estrada Muñoz L, Molina Roldán E, Cerón Nieto MÁ, Ortega Medina L, García Gómez de Las Heras S, Fernández Aceñero MJ. Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival. Virchows Arch 2018;473:687-95. [PMID: 30140949 DOI: 10.1007/s00428-018-2443-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gkolfinopoulos S, Papamichael D, Papadimitriou K, Papanastasopoulos P, Vassiliou V, Kountourakis P. Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making? World J Gastrointest Oncol 2018; 10(7): 172-183 [PMID: 30079143 DOI: 10.4251/wjgo.v10.i7.172] [Reference Citation Analysis]
12 Karthik S, Sudha M. Predicting bipolar disorder and schizophrenia based on non-overlapping genetic phenotypes using deep neural network. Evol Intel 2021;14:619-34. [DOI: 10.1007/s12065-019-00346-y] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Bhat SA, Mir MUR, Majid S, Hassan T, Rehman MU, Kuchy S. Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer. Hematol Oncol Stem Cell Ther 2018;11:158-68. [PMID: 29729225 DOI: 10.1016/j.hemonc.2018.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
14 Chen T, Xu XY, Zhou PH. Emerging molecular classifications and therapeutic implications for gastric cancer. Chin J Cancer. 2016;35:49. [PMID: 27233623 DOI: 10.1186/s40880-016-0111-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
15 Liu W, Lu Y, Chai X, Liu X, Zhu T, Wu X, Fang Y, Liu X, Zhang X. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases. J Exp Clin Cancer Res 2016;35:183. [PMID: 27887633 DOI: 10.1186/s13046-016-0464-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
16 Shi XJ, Wei Y, Ji B. Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment.Front Mol Biosci. 2020;7:203. [PMID: 33005629 DOI: 10.3389/fmolb.2020.00203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Song WM, Lin X, Liao X, Hu D, Lin J, Sarpel U, Ye Y, Feferman Y, Labow DM, Walsh MJ, Zheng X, Zhang B. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer. Int J Cancer 2020;146:1268-80. [PMID: 31463974 DOI: 10.1002/ijc.32643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
18 Huo X, Xiao X, Zhang S, Du X, Li C, Bai Z, Chen Z. Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor-related genes in gastric cancer. Oncol Lett 2021;21:430. [PMID: 33868468 DOI: 10.3892/ol.2021.12691] [Reference Citation Analysis]
19 Feng J, Li C, Xu R, Li Y, Hou Q, Feng R, Wang S, Zhang L, Li C. DpdtC-Induced EMT Inhibition in MGC-803 Cells Was Partly through Ferritinophagy-Mediated ROS/p53 Pathway. Oxid Med Cell Longev 2020;2020:9762390. [PMID: 32256964 DOI: 10.1155/2020/9762390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Li Y, Lu X, Tian P, Wang K, Shi J. Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt/mTOR signaling pathway. BMC Complement Med Ther 2021;21:76. [PMID: 33627124 DOI: 10.1186/s12906-021-03225-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Li F, Yi P, Pi J, Li L, Hui J, Wang F, Liang A, Yu J. QKI5-mediated alternative splicing of the histone variant macroH2A1 regulates gastric carcinogenesis. Oncotarget 2016;7:32821-34. [PMID: 27092877 DOI: 10.18632/oncotarget.8739] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
22 Oh S, Kim HS. Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies. Expert Rev Proteomics 2016;13:929-39. [PMID: 27599289 DOI: 10.1080/14789450.2016.1233063] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Liu Z, Long J, Du R, Ge C, Guo K, Xu Y. miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer. Tumor Biol 2016;37:8327-35. [DOI: 10.1007/s13277-015-4627-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
24 Adeola HA, Soyele OO, Adefuye AO, Jimoh SA, Butali A. Omics-based molecular techniques in oral pathology centred cancer: prospect and challenges in Africa. Cancer Cell Int 2017;17:61. [PMID: 28592923 DOI: 10.1186/s12935-017-0432-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Supplitt S, Karpinski P, Sasiadek M, Laczmanska I. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine. Int J Mol Sci 2021;22:1422. [PMID: 33572595 DOI: 10.3390/ijms22031422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Ghadami E, Nikbakhsh N, Fattahi S, Kosari‐monfared M, Ranaee M, Taheri H, Amjadi‐moheb F, Godazandeh G, Shafaei S, Nosrati A, Pilehchian Langroudi M, Samadani AA, Amirbozorgi G, Mirnia V, Akhavan‐niaki H. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections. J Cell Physiol 2019;234:4115-24. [DOI: 10.1002/jcp.27220] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
27 Chen X, Yang Y, Liu J, Li B, Xu Y, Li C, Xu Q, Liu G, Chen Y, Ying J, Duan S. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population. Oncotarget 2017;8:8105-19. [PMID: 28042954 DOI: 10.18632/oncotarget.14099] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
28 Guo C, Chen WD, Wang YD. TGR5, Not Only a Metabolic Regulator. Front Physiol 2016;7:646. [PMID: 28082913 DOI: 10.3389/fphys.2016.00646] [Cited by in F6Publishing: 64] [Reference Citation Analysis]
29 Hüneburg R, Marwitz T, van Heteren P, Weismüller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endosc Int Open 2016;4:E1305-10. [PMID: 27995193 DOI: 10.1055/s-0042-112582] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
30 Dai L, Zhuang L, Zhang B, Wang F, Chen X, Xia C, Zhang B. DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway. Int J Mol Sci 2015;16:28510-22. [PMID: 26633375 DOI: 10.3390/ijms161226116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
31 Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, Molina Roldán E, Cerón Nieto MÁ, García Gómez de Las Heras S, Fernández Aceñero MJ. Are Borrmann's Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study. Cancers (Basel) 2021;13:3081. [PMID: 34205546 DOI: 10.3390/cancers13123081] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Wang C, Wang R, Zhou K, Wang S, Wang J, Shi H, Dou Y, Yang D, Chang L, Shi X, Liu Y, Xu X, Zhang X, Ke Y, Liu H. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo. Cancer Chemother Pharmacol 2016;78:971-82. [PMID: 27620208 DOI: 10.1007/s00280-016-3149-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
33 Cai L, Li Y, Yang XW, Lian X, Guo M, Xiao SA, Wang WB, Zhang HW. Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy. Onco Targets Ther 2018;11:967-73. [PMID: 29503571 DOI: 10.2147/OTT.S152614] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Smolińska M, Grzanka D, Antosik P, Kasperska A, Neska-Długosz I, Jóźwicki J, Klimaszewska-Wiśniewska A. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters. Dis Markers 2019;2019:6315936. [PMID: 31737131 DOI: 10.1155/2019/6315936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Engebretsen S, Glad IK. Partially linear monotone methods with automatic variable selection and monotonicity direction discovery. Stat Med 2020;39:3549-68. [PMID: 32851696 DOI: 10.1002/sim.8680] [Reference Citation Analysis]
36 Sentani K, Imai T, Kobayashi G, Hayashi T, Sasaki N, Oue N, Yasui W. Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns. Gastric Cancer 2021;24:368-81. [PMID: 33118117 DOI: 10.1007/s10120-020-01133-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Yang L, Zhang S, Guo K, Huang H, Qi S, Yao J, Zhang Z. miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells. Onco Targets Ther 2019;12:205-15. [PMID: 30636883 DOI: 10.2147/OTT.S168454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]